Jarvik 2000 heart: potential for bridge to myocyte recovery.
BACKGROUND
Mechanical bridge to left ventricular recovery is an emerging strategy for the treatment of heart failure. We sought to validate the use of a new intracardiac axial flow impeller pump for this purpose.


RESULTS
The Jarvik 2000 Heart was implanted into 30 sheep to ascertain mechanical reliability, biocompatibility, and hemodynamic function. We attempted but failed to anticoagulate with warfarin. Elective explants with survival were performed in 3 animals to simulate bridge to recovery. Extensive autopsy studies were performed in all other animals. At speeds between 8000 and 12 000 rpm the device pumped up to 8 L/min, captured all mitral flow, and augmented cardiac output with elevation of mean arterial pressure. The pump was silent and hemolysis negligible. Nonpulsatile flow did not adversely affect neurological or renal function. Device removal proved straightforward and safe. A fractured inflow bearing occurred in 1 early model. There were no other pump failures, but power interruption occurred when the sheep chewed the cables or head-butted the percutaneous pedestal. At autopsy, there was no thromboembolism or primary thrombus formation in any device. Pump occlusion occurred in 2 sheep with bacterial endocarditis. One electively explanted pump, previously switched off for 5 months, had no thrombus in the device or vascular graft.


CONCLUSIONS
The Jarvik 2000 Heart is a major advance in blood-pump technology and increases the scope of mechanical circulatory support. Reliability and ease of removal favor its use for bridge to myocyte recovery, as well as for bridge to transplantation or long-term support.
Oxford Heart Centre, Oxford, UK.
S
S
Westaby
T
T
Katsumata
R
R
Houel
R
R
Evans
D
D
Pigott
O H
OH
Frazier
R
R
Jarvik
D000818:Animals; D004696:Endocarditis / Q000209:etiology; D006321:Heart / Q000502:physiology; D006331:Heart Diseases / Q000628:therapy*; D006353:Heart-Assist Devices / Q000009:adverse effects; D006439:Hemodynamics; D006461:Hemolysis / Q000502:physiology; D066298:In Vitro Techniques; D007432:Intraoperative Period; D008168:Lung / Q000473:pathology; D009017:Morbidity; D009026:Mortality; D009206:Myocardium / Q000473:pathology; D011652:Pulmonary Circulation / Q000502:physiology; D011673:Pulsatile Flow / Q000502:physiology; D012756:Sheep